ArQule Inc (ARQL.W)
3.13USD
5 Feb 2010
$0.01 (+0.32%)
$3.13
--
$3.13
$3.06
126,276
185,591
$6.38
$2.62
ARQL.W
About
Overall
| Beta: | 1.30 |
| Market Cap (Mil.): | $138.09 |
| Shares Outstanding (Mil.): | 44.69 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| ARQL.W | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 1.99 | 3.76 |
| EPS (TTM): | 35.91 | -- | -- |
| ROI: | -40.67 | 0.96 | 2.30 |
| ROE: | -104.20 | 1.31 | 2.82 |
UPDATE 1- ArQule Q3 beats estimates, sees narrower '09 loss
Nov 5 (Reuters) - Biotechnology company ArQule Inc posted a narrower quarterly loss as its revenue more than doubled on additional sales generated from its collaboration with Japan's Daiichi Sankyo Co Ltd .
After Medarex buy, biotech investors ask who's next
NEW YORK (Reuters) - Investors bid up shares of Regeneron Pharmaceuticals Inc and Seattle Genetics Inc on Thursday after Medarex Inc agreed to be acquired by Bristol-Myers Squibb Co at a 90 percent premium.
After Medarex buy, biotech investors ask who's next
NEW YORK (Reuters) - Investors bid up shares of Regeneron Pharmaceuticals Inc and Seattle Genetics Inc on Thursday after Medarex Inc agreed to be acquired by Bristol-Myers Squibb Co at a 90 percent premium.
UPDATE 1-After Medarex buy, biotech investors ask who's next
* Regeneron, Seattle Genetics potential targets - analyst
US RESEARCH SUMMARY-S&P 500 April 3 1659 GMT
Following is a summary of research actions on S&P 500 companies reported by
UPDATE 1-ArQule and Japan's Daiichi to develop cancer drugs
* To co-develop cancer treatments with Daiichi-Sankyo
UPDATE 1-Susquehanna starts 10 biotech cos with positive
Oct 21 (Reuters) - Susquehanna Financial Group began coverage of 10 biotechnology firms with a "positive" rating, and said the companies offered strong development capabilities and broad commercial potential in oncology and inflammation.
US RESEARCH SUMMARY-Non-S&P 500 Sept 3 1530 GMT
Following is a summary of research actions on non-S&P 500 and Canadian companies reported by Reuters on Wednesday. Stock entries are in alphabetical order. For a summary of research on S&P 500 companies, double click on [RCH/US] --------------------------------------------------------------- ------------ STOCK RESEARCH BY ACTION Adolor Piper Jaffray Cuts to neutral from buy,
ArQule says CEO plans to leave
Jan 7 (Reuters) - Biotechnology company ArQule Inc said Chief Executive Officer Stephen Hill plans to leave the company in early 2008 to pursue other career interests.
US RESEARCH NEWS-Friedman starts Safeway with market perform
Following are the research actions reported by Reuters on Monday. For actions reported earlier today, please double click on [nBNG39622] For a snapshot of research actions, please double click on [SNAP/RCH] ---------------------------------------------------------------- ----------- STOCK RESEARCH BY ACTION Safeway Friedman Billings Starts with market perform --------------------------------------------------------------- ------------ Kroger &
Competitors
| Price | Change | |
|---|---|---|
| Bristol Myers Squibb Co. (BMY.N) | $23.89 | -0.36 |
| Bristol Myers Squibb Co. (BMY_p.N) | $439.50 | 0.00 |
| OSI Pharmaceuticals, Inc. (OSIP.OQ) | $33.90 | -0.28 |
| Onyx Pharmaceuticals, Inc. (ONXX.OQ) | $28.80 | -0.25 |
| Vertex Pharmaceuticals Incorporated (VRTX.OQ) | $37.12 | -0.78 |
| Exelixis, Inc. (EXEL.OQ) | $6.31 | -0.11 |
| Cell Genesys, Inc. (CEGE.OQ) | -- | -- |
| Infinity Pharmaceuticals Inc. (INFI.OQ) | $6.08 | -0.03 |
| Array BioPharma Inc. (ARRY.OQ) | $2.32 | -0.08 |
| Idera Pharmaceuticals, Inc. (IDRA.OQ) | $4.65 | -0.05 |
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
